The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer. - Hermán-Sánchez N; G-García ME; Jiménez-Vacas JM; Yubero-Serrano EM; López-Sánchez LM; Romero-Martín S; Raya-Povedano JL; Álvarez-Benito M; Castaño JP; Luque RM; Gahete MD (Cellular and molecular life sciences : CMLS, 2024)